What is Macro Trials?
Macro Trials operates as a high-performance clinical trial site network, bridging the gap between pharmaceutical sponsors and diverse patient populations. The company provides a centralized operational framework that alleviates the administrative burden on investigators, ensuring rigorous protocol adherence and rapid data collection. By focusing on high-demand therapeutic areas such as ophthalmology, dermatology, and pulmonology, Macro Trials addresses the critical need for efficient, reliable, and scalable clinical research infrastructure in the United States. Their model is specifically engineered to enhance patient access to advanced therapies while maintaining the highest standards of clinical integrity.
How much funding has Macro Trials raised?
Macro Trials has raised a total of $6M across 1 funding round:
Angel/Seed
$6M
Angel/Seed (2023): $6M with participation from MBX Capital, villageglobal.com, Healthy VC, Inflict Health, and INITIATE Ventures
Key Investors in Macro Trials
MBX Capital
MBX Capital is a boutique venture capital firm that partners with and creates healthcare and biotechnology companies that are disrupting conventions in service to public health.
Village Global
Village Global VC is an early-stage venture capital firm that supports startups with funding, mentorship, and access to a network of successful entrepreneurs and investors.
Healthy VC
Undisclosed investor participating in the funding round.
What's next for Macro Trials?
Looking ahead, the strategic deployment of this capital will likely focus on expanding the company's geographic footprint and enhancing its proprietary site activation technology. As Macro Trials moves beyond its initial development phase, the focus will shift toward optimizing trial execution speed and deepening its integration with major CROs. The company is poised to capitalize on the growing demand for decentralized and high-efficiency clinical research solutions, potentially setting a new benchmark for site performance and patient recruitment in the biopharmaceutical industry. Future growth will be driven by the continued refinement of its operational model and the strategic recruitment of experienced clinical investigators.
See full Macro Trials company page
